PBE Invesco Dynamic Biotech & Genome ETF
Dynamic Biotech&Genome Intellidex TR USD

NAV as of 30-Nov-2022

66.7000

4 Week: 62.45 - 66.62

52 Week: 52.10 - 72.36

Latest Closing Price

66.62

Premium / Discount

0.11

Expense Ratio

0.57%

Investment Objective

The investment seeks to track the investment results (before fees and expenses) of the Dynamic Biotech & Genome IntellidexSM Index. The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index. The underlying index was composed of common stocks of U.S. biotechnology and genome companies. These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc. It is non-diversified.

Main Fund Characteristics

Fund Manager:
Invesco
Asset Under Management:
254,944,172
Launch Date:
22/06/2005
Asset Class:
Equity
Replication Method:
Physical-Full
Number of Holdings:
32
Trading Currency:
USD
Style:
Mid Growth
Region/Sector/Strategy:
N.A / Healthcare / N.A
Exchange:
NYSE

Performance

Period Performance Returns(%) Volatility(%) Risk Adjusted Performance
YTD-6.441.92-3.35
1 Day3.650.000.00
1 Week2.514.440.57
1 Month3.986.770.59
3 Months9.9914.090.71
6 Months13.4620.210.67
1 Year-5.4930.46-0.18
2 Years4.2838.680.11
3 Years20.3952.420.39
5 Years44.3362.700.71
10 Years185.8185.132.18

Price History

-

Annual Performance Return

2012201320142015201620172018201920202021
Price (%) 14.015061.679836.39652.0088-23.023022.42520.236718.249125.49881.5543
Nav (%) 0.00000.00000.00000.00000.00000.00000.00000.00000.00000.0000
Rank 89.000011.00001.000096.000093.000052.000052.000089.000041.000072.0000

Dividend Frequency

Lastest Dividend

Ex Date Payment Date Dividend Payout per unit
15/12/201629/12/20160.1208
18/09/201430/10/20140.0431
19/06/201429/06/20140.2340
17/12/200930/12/20090.0755

Portfolio Data

Total Number of Holdings: 32

Number of Bond Holdings: 0

Number of Equity Holdings: 30

Total Market Value: 254,944,172

Portfolio Composition

Top 10 Holdings

% Portfolio Weight Shares Owned Shares Changed Market Value
1Pacific Biosciences of California Inc5.6381962,497013,070,709

Country Exposure

Regional Exposure

America

Greater Europe

Greater Asia

Market Classification

Market Capitalization

Size% of portfolio
Giant0.00
Large30.80
Medium29.73
Small12.14
Micro27.33

Equity Style Box Breakdown

000Large
000Mid
000Small
ValueBlendGrowth

Value Measures

Price/Prospective Earnings*

6.6729

Price/Book*

2.6977

Price/Sales*

3.2904

Price/Cash Flow*

6.3179

Dividend Yield*

0.4275

Growth Measures

Long-Term Earnings

11.4457

Historical Earnings

22.9713

Sales Growth

21.2351

Cash-Flow Growth

21.3218

Book-Value Growth

13.0892

*Forward-looking based on historical data.

Equity Sector

Number of Bond Holdings

0

Bond Statitics

DetailValue
Average Effective Duration0
Average Effective Maturity (Years)*0
Average Credit Quality0
Average Weighted Coupon*0
Average Weighted Price*0

Bond Style Box Breakdown

000HighQuality
000Med
000Low
LtdModExt
Interest-Rate Sensitivity

Credit Quality

Type% Bonds
N.A

Bond Sector

Type
% Bonds

Bond Maturity

% Bonds
N.A

Data Source: Morningstar

© 2019 Morningstar. All Rights Reserved. The information, data, analyses and opinions (“Information”) contained herein:

(1) include the proprietary information of Morningstar and Morningstar’s third party licensors;
(2) may not be copied or redistributed except as specifically authorised;
(3) do not constitute investment advice;
(4) are provided solely for informational purposes;
(5) are not warranted to be complete, accurate or timely; and
(6) may be drawn from fund data published on various dates.

Morningstar and Phillip Securities Pte Ltd are not responsible for any trading decisions, damages or other losses related to the Information or its use. Please verify all of the Information before using it and don’t make any investment decision except upon the advice of a professional financial adviser. Past performance is no guarantee of future results. The value and income derived from investments may go down as well as up.

For the most up-to-date fund’s data and information, a copy of the fund factsheet, information or prospectus may be obtained from the respective ETF issuer.